Identification and Validation of a Seizure-Free-Related Gene Signature for Predicting Poor Prognosis in Lower-Grade Gliomas

References

• Xiao H, Bai J, Yan M, et al. Discovery of 5-signature predicting survival of patients with lower-grade glioma. World Neurosurg. 2019;126:e765–e772. doi:10.1016/j.wneu.2019.02.147
   PubMed Web of Science ®Google Scholar
• van Breemen MSM, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6(5):421–430. doi:10.1016/S1474-4422(07)70103-5
   PubMed Web of Science ®Google Scholar
• You G, Sha Z-Y, Yan W, et al. Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study. Neuro Oncol. 2012;14(2):230–241. doi:10.1093/neuonc/nor205
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Fan X, et al. Putamen involvement and survival outcomes in patients with insular low-grade gliomas. J Neurosurg. 2017;126(6):1788–1794. doi:10.3171/2016.5.JNS1685
   PubMed Web of Science ®Google Scholar
• Pouratian N, Mut M, Jagannathan J, Lopes MB, Shaffrey ME, Schiff D. Low-grade gliomas in older patients: a retrospective analysis of prognostic factors. J Neurooncol. 2008;90(3):341. doi:10.1007/s11060-008-9669-3
   PubMed Web of Science ®Google Scholar
• Fan X, Li Y, Shan X, et al. Seizures at presentation are correlated with better survival outcomes in adult diffuse glioma: a systematic review and meta-analysis. Seizure. 2018;59:16–23. doi:10.1016/j.seizure.2018.04.018
   PubMed Web of Science ®Google Scholar
• Lote K, Stenwig AE, Skullerud K, Hirschberg H. Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer. 1998;34(1):98–102. doi:10.1016/S0959-8049(97)00374-2
   PubMed Web of Science ®Google Scholar
• Phan K, Ng W, Lu VM, et al. Association between IDH1 and IDH2 mutations and preoperative seizures in patients with low-grade versus high-grade glioma: a systematic review and meta-analysis. World Neurosurg. 2018;111:e539–e545. doi:10.1016/j.wneu.2017.12.112
   PubMed Web of Science ®Google Scholar
• Chen H, Judkins J, Thomas C, et al. Mutant IDH1 and seizures in patients with glioma. Neurology. 2017;88(19):1805–1813. doi:10.1212/WNL.0000000000003911
   PubMed Web of Science ®Google Scholar
• Venkatesh HS, Morishita W, Geraghty AC, et al. Electrical and synaptic integration of glioma into neural circuits. Nature. 2019;573(7775):539–545. doi:10.1038/s41586-019-1563-y
   PubMed Web of Science ®Google Scholar
• Rudà R, Bello L, Duffau H, Soffietti R. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol. 2012;14(Suppl 4):iv55–64. doi:10.1093/neuonc/nos199
   PubMed Web of Science ®Google Scholar
• Zhang J, Yao L, Peng S, Fang Y, Tang R, Liu J. Correlation between glioma location and preoperative seizures: a systematic review and meta-analysis. Neurosurg Rev. 2019;42(3):603–618. doi:10.1007/s10143-018-1014-5
   PubMed Web of Science ®Google Scholar
• Zhou Z, Huang R, Chai R, et al. Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma. Aging. 2018;10(11):3185–3209. doi:10.18632/aging.101625
   PubMedGoogle Scholar
• Jang BS, Kim IA. A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA. Radiother Oncol. 2018;128(2):245–253. doi:10.1016/j.radonc.2018.05.003
   PubMed Web of Science ®Google Scholar
• Ahluwalia P, Mondal AK, Bloomer C, et al. Identification and clinical validation of a novel 4 gene-signature with prognostic utility in colorectal cancer. Int J Mol Sci. 2019;20(15):3818. doi:10.3390/ijms20153818
   PubMed Web of Science ®Google Scholar
• Wu M, Li X, Zhang T, Liu Z, Zhao Y. Identification of a nine-gene signature and establishment of a prognostic nomogram predicting overall survival of pancreatic cancer. Front Oncol. 2019;9:996. doi:10.3389/fonc.2019.00996
   PubMed Web of Science ®Google Scholar
• Colaprico A, Silva TC, Olsen C, et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71–e71. doi:10.1093/nar/gkv1507
   PubMed Web of Science ®Google Scholar
• Wang L, Li Z, Song X, Liu L, Su G, Cui Y. Bioinformatic analysis of genes and MicroRNAs associated with atrioventricular septal defect in down syndrome patients. Int Heart J. 2016;57(4):490–495. doi:10.1536/ihj.15-319
   PubMed Web of Science ®Google Scholar
• He P, Zhang Z, Liao W, Xu D, Fu M, Kang Y. Screening of gene signatures for rheumatoid arthritis and osteoarthritis based on bioinformatics analysis. Mol Med Rep. 2016;14(2):1587–1593. doi:10.3892/mmr.2016.5423
   PubMed Web of Science ®Google Scholar
• Ruan L, Xie Y, Liu F, Chen X. Serum miR-1181 and miR-4314 associated with ovarian cancer: miRNA microarray data analysis for a pilot study. Eur J Obstet Gynecol Reprod Biol. 2018;222:31–38. doi:10.1016/j.ejogrb.2018.01.006
   PubMed Web of Science ®Google Scholar
• Wang R, Li J, Zhao Y, Li Y, Yin L. Investigating the therapeutic potential and mechanism of curcumin in breast cancer based on RNA sequencing and bioinformatics analysis. Breast Cancer. 2018;25(2):206–212. doi:10.1007/s12282-017-0816-6
   PubMed Web of Science ®Google Scholar
• Ouyang D, Li R, Li Y, Zhu X. A 7-lncRNA signature predict prognosis of Uterine corpus endometrial carcinoma. J Cell Biochem. 2019;120(10):18465–18477. doi:10.1002/jcb.29164
   PubMed Web of Science ®Google Scholar
• Xiao K, Liu Q, Peng G, Su J, Qin C-Y, Wang X-Y. Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma. PeerJ. 2020;8:e8312. doi:10.7717/peerj.8312
   PubMed Web of Science ®Google Scholar
• Scott GM, Gibberd FB. Epilepsy and other factors in the prognosis of gliomas. Acta Neurol Scand. 1980;61(4):227–239. doi:10.1111/j.1600-0404.1980.tb01487.x
   PubMed Web of Science ®Google Scholar
• Xue J, Gao HX, Sang W, et al. Identification of core differentially methylated genes in glioma. Oncol Lett. 2019;18(6):6033–6045.
   PubMed Web of Science ®Google Scholar
• Razmkhah M, Arabpour F, Taghipour M, Mehrafshan A, Chenari N, Ghaderi A. Expression of chemokines and chemokine receptors in brain tumor tissue derived cells. Asian Pac J Cancer Prev. 2014;15(17):7201–7205. doi:10.7314/APJCP.2014.15.17.7201
   PubMedGoogle Scholar
• Hu Y, Lai Y. Identification and expression analysis of rice histone genes. Plant Physiol Biochem. 2015;86:55–65. doi:10.1016/j.plaphy.2014.11.012
   PubMed Web of Science ®Google Scholar
• Dong S, Li W, Wang L, et al. Histone-related genes are hypermethylated in lung cancer and hypermethylated HIST1H4F could serve as a pan-cancer biomarker. Cancer Res. 2019;79(24):6101–6112. doi:10.1158/0008-5472.CAN-19-1019
   PubMed Web of Science ®Google Scholar
• Wojtasz L, Daniel K, Roig I, et al. Mouse HORMAD1 and HORMAD2, two conserved meiotic chromosomal proteins, are depleted from synapsed chromosome axes with the help of TRIP13 AAA-ATPase. PLoS Genet. 2009;5(10):e1000702. doi:10.1371/journal.pgen.1000702
   PubMed Web of Science ®Google Scholar
• Liu M, Chen J, Hu L, et al. HORMAD2/CT46.2, a novel cancer/testis gene, is ectopically expressed in lung cancer tissues. Mol Hum Reprod. 2012;18(12):599–604. doi:10.1093/molehr/gas033
   PubMed Web of Science ®Google Scholar